Omnicell Inc. Stock
Price
Target price
€25.60
€25.60
-2.290%
-0.6
-2.290%
€51.63
24.04.24 / Frankfurt
WKN: 632313 / Symbol: OMCL / Name: Omnicell / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Omnicell Inc. Stock
We can see a decrease in the price for Omnicell Inc.. Compared to yesterday it has lost -€0.600 (-2.290%).
With 2 Buy predictions and 2 Sell predictions the community is currently undecided on Omnicell Inc..
With a target price of 51 € there is a hugely positive potential of 99.22% for Omnicell Inc. compared to the current price of 25.6 €.
Pros and Cons of Omnicell Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omnicell Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Omnicell Inc. | -2.290% | 7.377% | 2.344% | -53.214% | -25.143% | -76.814% | -60.790% |
Integer Hldg | 5.500% | -0.909% | 1.869% | 48.299% | 22.472% | 42.484% | 75.185% |
Healthequity Inc. | -1.340% | -0.667% | 1.361% | 46.078% | 25.210% | 22.897% | - |
Bruker Corp. | 0.180% | -1.132% | -11.678% | - | 15.549% | - | - |
Comments
Omnicell, Inc. (NASDAQ: OMCL) had its price target lowered by analysts at Benchmark Co. from $42.00 to $38.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell, Inc. (NASDAQ: OMCL) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $33.00 price target on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell, Inc. (NASDAQ: OMCL) had its price target lowered by analysts at Wells Fargo & Company from $56.00 to $39.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for OMCL provided by MarketBeat